HOME > PRESS RELEASE > 2017 >

NHI Drug Price Listing for Bipresso® Extended Release Tablets for the Improvement of Depressive Symptoms Associated with Bipolar Disorder Announced

PRESS RELEASE

NHI Drug Price Listing for Bipresso® Extended Release Tablets for the Improvement of Depressive Symptoms Associated with Bipolar Disorder Announced

2017/08/30

Kyowa Pharmaceutical Industry Co., Ltd. announced the listing of the NHI (National Health Insurance) drug price for Bipresso®(generic name: Quetiapine Fumarate) extended release 50mg and 150 mg tablets for the treatment of depressive symptoms associated with bipolar disorder. 

Back

PRESS RELEASE